Fish oil

About: Fish oil is a research topic. Over the lifetime, 9887 publications have been published within this topic receiving 367953 citations. The topic is also known as: fish oils & Fish oil.

Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension.

Abstract: pressures related to situation and the influence of other drug users. In the outpatient group the most risky times appeared to be at the beginning and end of the withdrawal schedule. Six subjects (21% ofthis group) failed in the first 14 days of the eight week programme, and 9 (31%) failed in the last week. Ofthe six inpatients who failed, two did so on the first day and the four others in the last six days. The outpatient sample was more likely to remain in contact with the hospital's drug dependence services (x2=9 19, p

Reducing the levels of dioxins and dioxin-like PCBs in farmed Atlantic salmon by substitution of fish oil with vegetable oil in the feed

Abstract: Atlantic salmon were fed extruded diets based on either 100% fish oil (FO) or 100% vegetable oil blend (VO) substitution for 22 months. A total of seven distinct feeding periods were studied that incorporated higher levels of dietary oil inclusion, and larger pellet size as fish size increased. Whole fish levels of polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/F) and dioxin-like PCBs (DLPCB) were analysed at the beginning and end of each of the seven feeding periods. The PCDD/F and DLPCB concentrations in the FO diets increased from 2.43 to 4.74 ng WHO-TEQ kg−1 (TEQ, toxic equivalents), while VO diets decreased from 1.07 to 0.33 WHO-TEQ kg−1 as oil inclusion increased. Partial least square regression analyses identified feed concentration, growth rate and feed utilization, but not variations in lipid content, as factors significantly affecting fish PCDD/F and DLPCB levels. Accumulation efficiencies for DLPCB (740 ± 90 g kg−1) were significantly (P < 0.01) higher than for PCDD/F (430 ± 60 g kg−1), explaining the increasing dominance of DLPCB levels over PCDD/F levels in whole fish (DLPCB : PCDD/F ratio of 2.4 ± 0.1 for both VO and FO fed fish) compared with feed (DLPCB : PCDD/F ratio of 1.5 and 0.34 for FO and VO feed respectively). Vegetable oil substitution significantly reduced the level of PCDD/F and DLPCB (eightfold and twelve-fold, respectively) in the fillet of a 2 kg salmon, but, also negatively affected beneficial health components such as fillet n-3/n-6 fatty acid ratio.

Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway.

Abstract: The effect of fish oils and their active omega-3 fatty acid constituents, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), were investigated on breast cancer growth. In in vivo experiments, mice were fed diets that were rich in either omega-3 (fish oil) or omega-6 (corn oil) fatty acids. Three weeks after implantation of MDA-MB-231 breast cancer cells, the tumor volume and weight were significantly lower (p < 0.05) for mice fed the omega-3 diets compared to those fed the omega-6 diets. Dietary fish oil also caused a 40% (p < 0.05) increase in neutral sphingomyelinase (N-SMYase) activity in the tumors. The tumor tissues from fish oil-fed animals expressed elevated p21 (waf1/cip1) mRNA, whereas tumor tissues from corn oil-fed animals exhibited undetectable levels of p21 expression. In in vitro experiments, at concentrations as low as 25 muM, DHA and EPA inhibited the growth of cultured MDA-MB-231 cells in a dose-dependent manner by 20-25% (p < 0.05). N-SMYase activity was also increased by 30-40% (p < 0.05) in the DHA- or EPA-treated cells in which an increase in ceramide formation was observed. DHA and EPA were both observed to enhance membrane bleb formation and also to induce the expression of p21. Omega-3 fatty acids-induced bleb formation and p21 expression were inhibited by the N-SMYase inhibitor GW4869, which also inhibited apoptosis by approximately 40% (p < 0.05). The results suggest that inhibition of breast cancer growth in nude mice by dietary fish oil and inhibition of breast cancer cell growth in culture by treatment with DHA and EPA is mediated by activation of N-SMYase.

The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene-synthesizing capacity in patients with postoperative trauma.

Abstract: The incorporation of omega-3 and omega-6 fatty acids (FAs) into leukocyte membranes and the leukotriene (LT)B4-, LTB5 -, LTC4-, and LTCs-synthesizing capacity in stimulated leukocytes were measured following parenteral omega-3 FA nutrition in 20 postoperative patients. Total parenteral nutrition (TPN) over 5 days postoperatively was isonitrogenous (0.24 g N x kg-1 x d1) and isoenergetic (92 kJ/22 kcal x kg-1 x d-1), containing 0.15 g fish oil and 0.85 g soybean oil per kg-1 x d-1 (FO) or 1.0 g soybean oil x kg-1 x d-1 (SO). Following 5 days' FO administration, the content of eicosapentaenoic acid (EPA) was increased 2.5-fold, LTB5 1.5-fold, and LTC5 sevenfold. With SO nutrition, EPA and LTB5 generation remained unaltered, whereas LTC5 doubled. The production of LTB4 and LTC4 was not affected in any of the groups. We conclude that a 5-day parenteral fish oil supplementation has an immunomodulatory effect on lipid-mediator generation in human leukocytes in postoperative trauma.

Algae in Fish Feed: Performances and Fatty Acid Metabolism in Juvenile Atlantic Salmon

Abstract: Algae are at the base of the aquatic food chain, producing the food resources that fish are adapted to consume. Previous studies have proven that the inclusion of small amounts (<10% of the diet) of algae in fish feed (aquafeed) resulted in positive effects in growth performance and feed utilisation efficiency. Marine algae have also been shown to possess functional activities, helping in the mediation of lipid metabolism, and therefore are increasingly studied in human and animal nutrition. The aim of this study was to assess the potentials of two commercially available algae derived products (dry algae meal), Verdemin (derived from Ulva ohnoi) and Rosamin (derived from diatom Entomoneis spp.) for their possible inclusion into diet of Atlantic Salmon (Salmo salar). Fish performances, feed efficiency, lipid metabolism and final product quality were assessed to investigated the potential of the two algae products (in isolation at two inclusion levels, 2.5% and 5%, or in combination), in experimental diets specifically formulated with low fish meal and fish oil content. The results indicate that inclusion of algae product Verdemin and Rosamin at level of 2.5 and 5.0% did not cause any major positive, nor negative, effect in Atlantic Salmon growth and feed efficiency. An increase in the omega-3 long-chain polyunsaturated fatty acid (n-3 LC-PUFA) content in whole body of fish fed 5% Rosamin was observed.